Pfenex Inc
-
Ticker
PFNX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in San Diego, California
Pfenex Inc., a clinical-stage biotechnology company, develops biosimilar therapeutics. Its lead product candidate is PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in patients with wet age-related macular degeneration.
REPORT RATINGS
4.8 / 5.0 (118)
Pfenex Inc reports have an aggregate usefulness score of 4.8 based on 118 reviews.
Pfenex Inc
Most Recent Annual Report
MOST RECENT
2019 Annual Report
Older/Archived Annual Reports